| Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157. e13, 2020 | 700 | 2020 |
| Identification of galectin-3 as an autoantigen in patients with IgG4-related disease CA Perugino, SB AlSalem, H Mattoo, E Della-Torre, V Mahajan, ... Journal of Allergy and Clinical Immunology 143 (2), 736-745. e6, 2019 | 163 | 2019 |
| Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis T Maehara, N Kaneko, CA Perugino, H Mattoo, J Kers, H Allard-Chamard, ... The Journal of clinical investigation 130 (5), 2451-2464, 2020 | 148 | 2020 |
| CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease CA Perugino, N Kaneko, T Maehara, H Mattoo, J Kers, H Allard-Chamard, ... Journal of Allergy and Clinical Immunology 147 (1), 368-382, 2021 | 64 | 2021 |
| Interleukin-15 in autoimmunity H Allard-Chamard, HK Mishra, M Nandi, M Mayhue, A Menendez, ... Cytokine 136, 155258, 2020 | 52 | 2020 |
| ADE and hyperinflammation in SARS-CoV2 infection-comparison with dengue hemorrhagic fever and feline infectious peritonitis M Cloutier, M Nandi, AU Ihsan, HA Chamard, S Ilangumaran, ... Cytokine 136, 155256, 2020 | 50 | 2020 |
| Massachusetts Consortium on Pathogen Readiness Specimen Working Group Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157, 2020 | 47 | 2020 |
| Induction of metabolic quiescence defines the transitional to follicular B cell switch JR Farmer, H Allard-Chamard, N Sun, M Ahmad, A Bertocchi, ... Science signaling 12 (604), eaaw5573, 2019 | 40 | 2019 |
| Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions H Allard-Chamard, N Carrier, P Dufort, M Durand, AJ de Brum-Fernandes, ... Bone Reports 12, 100282, 2020 | 26 | 2020 |
| Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study MA Matza, CA Perugino, L Harvey, AD Fernandes, ZS Wallace, H Liu, ... The Lancet Rheumatology 4 (2), e105-e112, 2022 | 22 | 2022 |
| B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers VS Mahajan, H Mattoo, N Sun, V Viswanadham, GJ Yuen, ... Nature communications 12 (1), 2208, 2021 | 19 | 2021 |
| Prostaglandin production by human osteoclasts in culture. JA Hackett, H Allard-Chamard, P Sarrazin, M de Fatima Lucena, ... The Journal of Rheumatology 33 (7), 1320-1328, 2006 | 18 | 2006 |
| CD4+ CTLs in fibrosing mediastinitis linked to Histoplasma capsulatum H Allard-Chamard, F Alsufyani, N Kaneko, K Xing, C Perugino, ... The Journal of Immunology 206 (3), 524-530, 2021 | 17 | 2021 |
| Antineutrophil cytoplasmic antibodies testing and interpretation H Allard-Chamard, P Liang Clinics in laboratory medicine 39 (4), 539-552, 2019 | 16 | 2019 |
| An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production K Mathurin, MA Gallant, P Germain, H Allard-Chamard, J Brisson, ... Journal of biological chemistry 286 (4), 2696-2706, 2011 | 14 | 2011 |
| Extrafollicular IgD− CD27− CXCR5− CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19 H Allard-Chamard, N Kaneko, A Bertocchi, N Sun, J Boucau, HH Kuo, ... Cell Reports 42 (6), 2023 | 13 | 2023 |
| Serologic diagnosis of rheumatoid arthritis H Allard-Chamard, G Boire Clinics in Laboratory Medicine 39 (4), 525-537, 2019 | 13 | 2019 |
| IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells JH Newman, A Shaver, JH Sheehan, S Mallal, JH Stone, S Pillai, ... Molecular genetics & genomic medicine 7 (6), e686, 2019 | 11 | 2019 |
| Cytosolic phospholipase A2 and eicosanoids modulate life, death and function of human osteoclasts in vitro H Allard-Chamard, P Dufort, S Haroun, AJ de Brum-Fernandes Prostaglandins, Leukotrienes and Essential Fatty Acids 90 (4), 117-123, 2014 | 9 | 2014 |
| Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre … CA Perugino, ZS Wallace, DJ Zack, SM Quinn, A Poma, AD Fernandes, ... The Lancet Rheumatology 5 (8), e442-e450, 2023 | 8 | 2023 |
